The Pros And Cons Of A Career In Drug Development:
- April 27th, 2010
-
Title: The Pros And Cons Of A Career In Drug Development:
Location: Takeda San Diego
Link out: Click here
Description: About the Speaker:
Mr. Crouch has 25 years of drug development and commercialization experience spanning large pharmaceutical companies, biotech, and the CRO industry. Most recently, he was Senior Vice President of Operations and President International at Ligand Pharmaceuticals (Nasdaq: LGND), with responsibilities for new business development, technical operations (manufacturing, clinical and commercial drug supply, CMC) as well as international sales, clinical research, and regulatory affairs. Prior to Ligand, he was President and COO of Discovery Partners, a large drug discovery services and technology provider. Earlier in his career he was CEO of Variagenics (a leading pharmacogenomics company), SVP Marketing and Sales at Parexel (a global CRO), and he held international management positions in new product development and commercialization at Pfizer and Schering Plough. Mr. Crouch previously served on the board of Bruker Biosciences (Nasdaq: BRKR), a major provider of analytical instrumentation to the life sciences industry. Mr. Crouch has a BSE in chemical engineering, cum laude, from Princeton University and an MBA in international marketing and finance from the University of Chicago.About the Lecture:
Taylor Crouch, CEO of eStudySite, will discuss the pros and cons of pursuing a career in drug development. Mr. Crouch will highlight the drug development process, covering many of the steps involved, functions, and issues associated with drug development. Drawing on his experience across the pharma landscape, from large pharmaceutical companies, biotechs, CROs, and most recently in clinical research, this seminar will provide a backdrop and discussion about the industry. This seminar will perhaps provide food for thought to those interested in this industry as a career path, or to those already working in this industry and struggling to address the changes and challenges around them.
Start Time: 18:00:00
Date: 2010-04-27
End Time: 21:00:00 
Life After Graduate School & Your First Year On The Job:
- January 26th, 2010
-
Title: Life After Graduate School & Your First Year On The Job:
Location: LabAutomation2010, Palm Springs, CA, USA
Link out: Click here
Description: Returning for the third time to LabAutomation this year is a much improved one-day program focused on the transition from the academic world to the business world dealing with such sensitive items as interviewing skills, appropriate attire, relocation, cultural impacts, and much, much more. New this year, is a section dedicated specifically to early career professionals and focusing on the first year on the job.Instructor: Professor Joel Shulman, Ph.D., University of Cincinnati
Preparing For Life After Graduate School
8-10:30AM - Breakfast ServedRésumé Preparation: There\’s always room for improvement
Effective Interviewing for Industry: A trainable skill
What to Expect: Your First Year on the Job
12:30-3:30PM - Lunch ServedFirst Year on the Job: Getting started in your career
IP & Patents: What you need to know
Business Economics for R&D: A brief primer
Q&A Panel with Industry Leaders
For more information plesase visit
https://www.labautomation.org/LA10/studentprogram.cfm
Start Time: 08:00:00
Date: 2010-01-26
End Time: 15:30:00 
5th Annual SABPA Pacific Forum 2009 - “Riding the Wave”
- November 7th, 2009
-
This year the Forum has invited prominent industry leaders, journalist, such as Ted Plafker, bestselling author of “Doing Business in China, How to profit in the world’s fastest growing market” and Beijing Correspondent for “The Economist,” Joe Panetta, CEO of BIOCOM, Ivor Royston, Managing Partner of Forward Ventures, Howard Balloch, President of the Balloch Group

ACS Awards Banquet
- October 22nd, 2009
-
Chemistry, as the central science, is the great unifier of multidisciplinary endeavors. Nowhere is this more apparent than in the biotech/pharmaceutical sectors. But finding the key chemical principles and translating them effectively requires broad historical, technological, biomedical and business perspectives.

